Myelodysplastic Syndromes in the Postgenomic Era and Future Perspectives for Precision Medicine

SIMPLE SUMMARY: With demographic ageing, improved cancer survivorship and increased diagnostic sensitivity, incident cases of patients with Myelodysplastic Syndromes (MDS) are continuously rising, leading to a relevant impact on health care resources. Disease heterogeneity and various comorbidities...

Descripción completa

Detalles Bibliográficos
Autores principales: Chanias, Ioannis, Stojkov, Kristina, Stehle, Gregor Th., Daskalakis, Michael, Simeunovic, Helena, Njue, Linet Muthoni, Schnegg-Kaufmann, Annatina S., Porret, Naomi A., Allam, Ramanjaneyulu, Rao, Tata Nageswara, Benz, Rudolf, Ruefer, Axel, Schmidt, Adrian, Adler, Marcel, Rovo, Alicia, Balabanov, Stefan, Stuessi, Georg, Bacher, Ulrike, Bonadies, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267785/
https://www.ncbi.nlm.nih.gov/pubmed/34209457
http://dx.doi.org/10.3390/cancers13133296

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267785/
https://www.ncbi.nlm.nih.gov/pubmed/34209457
http://dx.doi.org/10.3390/cancers13133296

Ejemplares similares